Granules Q2 net rises 34% to ₹130 cr.

6 months ago 2
ARTICLE AD BOX

Generic drugmaker Granules India reported September 4th consolidated nett net accrued astir 34% to ₹130 crore compared to ₹97.2 crore a twelvemonth earlier.

The higher nett net came a much than 34% summation successful full gross from operations astatine astir ₹1,297 crore (₹966.6 crore).

It was a resilient fiscal show with steadfast maturation successful some gross and profitability. The betterment successful PAT reflects the continued absorption connected operational excellence, disciplined execution and the spot of governance, CMD Krishna Prasad Chigurupati said.

Finished dosages (FD), progressive pharmaceuticals ingredients (APIs), pharmaceutical formulation intermediates (PFI), and peptides/ CDMO contributed 74%, 13%, 10% and 2% to gross from operations respectively during the quarter.

“Our peptides CDMO level done Ascelis, anchored successful the bequest of Senn Chemicals successful Switzerland, is steadily gaining visibility, with renewed lawsuit involvement and promising caller discussions underway,” helium said successful a release. Granules shares closed 2.52% higher connected Thursday astatine ₹555.85 apiece connected the BSE.

The institution said among different things, the Board has approved acquisition of 100% involvement successful a caller company, optus 1039 GmBH, successful Frankfurt for euro 28,400 (nearly ₹29.10 lakh) arsenic portion of plans to found a wholly owned subsidiary successful Germany for the pharmaceutical business. The determination volition alteration Granules’ introduction into the B2C conception successful the European region. The acquisition is aimed astatine strengthening user engagement and driving focused maturation crossed cardinal European markets, it said.

Published - November 13, 2025 10:23 p.m. IST

Read Entire Article